LMLucas Hoyos Mejía

Lucas Hoyos Mejía

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lucas Hoyos Mejía has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Shin Tanaka

    Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    4 shared publications
  • Alejandra Romero Román

    Department of Thoracic Surgery and Lung Transplantation, Hospital Universitario Puerta de Hierro-Majadahonda, Calle Manuel de Falla s/n, Majadahonda, Madrid 28222, Spain

    2 shared publications
  • Alejandra Romero Román

    Department of Thoracic Surgery, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain

    2 shared publications
  • Andrés Varela

    Servicio de Cirugía Torácica, Hospital Universitario Puerta de Hierro, Madrid, España

    2 shared publications
  • Andrés Varela de Ugarte

    Department of Thoracic Surgery and Lung Transplantation, Hospital Universitario Puerta de Hierro-Majadahonda, Calle Manuel de Falla s/n, Majadahonda, Madrid 28222, Spain

    2 shared publications
  • David Gomez-De-Antonio

    Department of Thoracic Surgery and Lung Transplantation, Hospital Universitario Puerta de Hierro-Majadahonda, Universidad Autonoma de Madrid, Madrid, Spain

    2 shared publications

Latest Publications

  • Evaluation of Uncontrolled Donation After Circulatory Death Lungs by Conventional In Situ Effluent Gas Analysis and Ex Vivo Lung Perfusion

    by Shin Tanaka, Lucas Hoyos Mejía, Alejandra Romero Román, Jose Luis Campo-Cañaveral de la Cruz, Silvana Crowley Carrasco, Jose Manuel Naranjo Gómez, Maria del Mar Córdoba Peláez, Álvaro Sánchez Calle, Mariana Gil Barturen, Andrés Varela de Ugarte, et al.


  • Interrupted versus Continuous Suture for Bronchial Anastomosis in Lung Transplantation: Does It Matter?

    by M. Gil Barturen, M. Peyró Sánchez, S. Crowley Carrasco, A. Romero Román, L. Hoyos Mejía, S. Tanaka, G. Díaz Nuevo, C. López García-Gallo, J. Naranjo Gómez, A. Varela De Ugarte, et al.

  • Open Access

    Lung transplantation from uncontrolled and controlled donation after circulatory death: similar outcomes to brain death donors

    by Jose Luis Campo‐Cañaveral de la Cruz, Silvana Crowley Carrasco, Shin Tanaka, Alejandra Romero Román, Lucas Hoyos Mejía, Mariana Gil Barturen, Álvaro Sánchez Calle, Christian García Fadul, Myriam Aguilar Pérez, Marina Pérez Redondo, et al.

    Introduction Controlled donation after circulatory-death donors (cDCD) are becoming a frequent source of lungs grafts worldwide. Conversely, lung transplantations (LTx) from uncontrolled donors (uDCD) are sporadically reported. We aimed to review our institutional experience using both uDCD and cDCD and compare to LTx from brain death donors (DBD). Methods This is a retrospective analysis of all LTx performed between January 2013– December 2019 in our institution. Donor and recipient characteristics were collected and univariate, multivariate and survival analyses were carried out comparing the three cohorts of donors. Results A total of 239 (84.7%) LTx were performed from DBD, 29 (10.3%) from cDCD and 14 (5%) from uDCD. There were no statistically significant differences in primary graft dysfunction grade 3 at 72 hours, 30- and 90-day mortality, need for extracorporeal membrane oxygenation after procedure, ICU and hospital length of stay, airway complications, CLAD incidence or survival at 1 and 3 years after transplant (DBD: 87.1% and 78.1%; cDCD: 89.7% and 89.7%; uDCD: 85.7% and 85.7%, respectively; p=0.42). Short- and mid-term outcomes are comparable between the three types of donors. Conclusions These findings may encourage and reinforce all types of donation after circulatory-death programmes as a valid and growing source of suitable organs for transplantation.


  • Thoracic surgery during the coronavirus disease 2019 (COVID-19) pandemic in Madrid, Spain: single-centre report

    by Lucas Hoyos Mejía, Alejandra Romero Román, Mariana Gil Barturen, Maria del Mar Córdoba Pelaez, José Luis Campo-Cañaveral de la Cruz, José Manuel Naranjo, Silvana Crolwey Carrasco, Shin Tanaka, Alvaro Sánchez Calle, Andrés Varela de Ugarte, et al.

    OBJECTIVES: We reviewed the incidence of coronavirus disease 2019 cases and the postoperative outcomes of patients who had thoracic surgery during the beginning and at the highest point of transmission in our community. METHODS: We retrospectively reviewed patients who had undergone elective thoracic surgery from 12 February 2020 to 30 April 2020 and were symptomatic or tested positive for severe acute respiratory syndrome coronavirus 2 infection within 14 days after surgery, with a focus on their complications and potential deaths. RESULTS: Out of 101 surgical procedures, including 57 primary oncological resections, 6 lung transplants and 18 emergency procedures, only 5 cases of coronavirus disease 2019 were identified, 3 in the immediate postoperative period and 2 as outpatients. All 5 patients had cancer; the median age was 64 years. The main virus-related symptom was fever (80%), and the median onset of coronavirus disease 2019 was 3 days. Although 80% of the patients who had positive test results for severe acute respiratory syndrome coronavirus 2 required in-hospital care, none of them were considered severe or critical and none died. CONCLUSIONS: These results indicate that, in properly selected cases, with short preoperative in-hospital stays, strict isolation and infection control protocols, managed by a dedicated multidisciplinary team, a surgical procedure could be performed with a relatively low risk for the patient.